NEXUS PHARMACEUTICALS LLC
2025–2026 federal contribution records · FEC Schedule A
01
Contribution summary
Loading the financial summary…
Reading the shared contribution publication for this cycle.
2025–2026 federal contribution records · FEC Schedule A
Loading the financial summary…
Reading the shared contribution publication for this cycle.
Federal contribution records grouped across normalized variants of this reported employer. Contributions are made by individuals, not by the employer.
Current-version rows · memo entries excluded from net amount
Last updated .
A current recipient-party breakdown has not been published. Financial totals remain available; older party percentages are not shown.
Loading 10 contributions with dates…
Loading company overview…
These immutable labels appeared in FEC filings and are grouped under NEXUS PHARMACEUTICALS LLC.
Top 10 contributors and top 10 recipients · independent of list pagination
Explore the reported connections for Nexus Pharmaceuticals. Contributor and recipient lists are available below.
Data: GovMoneyGraph, based on FEC records. Groupings and recipient-party allocations are derived analysis, not FEC-verified identities or party registrations. Read our contribution and classification methodology.
Reported contributor groups, with evidence-based name-variant matching; not verified unique people · 10 per page
Showing 1–4 of 4 · largest absolute amount first
Reported name + ZIP cluster; not a verified identity merge · EVANSTON, IL, 60202 · NEXUS PHARMACEUTICALS · Healthcare & Pharmaceuticals · ATTORNEY · 8 transaction rows
Reported name + ZIP cluster; not a verified identity merge · VERNON HILLS, IL, 60061 · NEXUS PHARMACEUTICALS LLC · Healthcare & Pharmaceuticals · BOARD MEMBER · 3 transaction rows
Reported name + ZIP cluster; not a verified identity merge · VERNON HILLS, IL, 60061 · NEXUS PHARMACEUTICALS · Healthcare & Pharmaceuticals · CHIEF SCIENTIFIC OFFICER · 2 transaction rows
Reported name + ZIP cluster; not a verified identity merge · MIAMI, FL, 33137 · NEXUS PHARMACEUTICALS LLC · Healthcare & Pharmaceuticals · BOARD MEMBER · 1 transaction rows
Where the contributions went · 10 per page
Showing 1–5 of 5 · largest absolute amount first
House campaign committee · SKOKIE, IL · AMIWALA, BUSHRA · U.S. House IL 09 · 6 transaction rows
Super PAC · SILVER SPRING, MD · 1 transaction rows
House campaign committee · CHICAGO, IL · RAMIREZ, DELIA · U.S. House IL 03 · 3 transaction rows
Senate campaign committee · ST CLAIR SHORES, MI · EL-SAYED, ABDUL · U.S. Senate MI 00 · 2 transaction rows
PAC (not qualified) · CHICAGO, IL · 2 transaction rows
Individual transactions · 10 per page
Dates below are the FEC-reported contribution dates, not filing or import dates. These are individual contributions grouped by the reported employer field, not contributions by a company.
Largest contribution amounts first. Select Date of contribution or Amount to reverse the order.
| Date of contribution ↕ | Amount ↓ | Reported contributor / location | Recipient / filing |
|---|---|---|---|
| 2026-06-24FEC filing ↗ | $20,000 | AHMED, AYESHAEVANSTONIL60202ATTORNEYNEXUS PHARMACEUTICALS | ACTBLUEC00401224Primary (P)EARMARKED FOR FIGHTING FOR MICHIGAN PAC (C00919373)Filing 2000535 |
| 2026-06-10FEC filing ↗ | $3,500 | AHMED, AYESHAEVANSTONIL60202ATTORNEYNEXUS PHARMACEUTICALS | ACTBLUEC00401224Primary (P)EARMARKED FOR ABDUL FOR U.S. SENATE (C00902668)Filing 2000535 |
| 2026-05-15FEC filing ↗ | $3,500 | AHMED, AYESHAEVANSTONIL60202ATTORNEYNEXUS PHARMACEUTICALS | UNITED WITH DELIA FOR CONGRESSC00796672General 2026 (G2026)* EARMARKED CONTRIBUTION: SEE BELOWFiling 2001360 · amended |
| 2026-06-15FEC filing ↗ | $3,500 | AHMED, AYESHAEVANSTONIL60202ATTORNEYNEXUS PHARMACEUTICALS | ACTBLUEC00401224Primary (P)EARMARKED FOR ABDUL FOR U.S. SENATE (C00902668)Filing 2000535 |
| 2025-12-28FEC filing ↗ | $3,500 | AHMED, SHAHIDVERNON HILLSIL60061CHIEF SCIENTIFIC OFFICERNEXUS PHARMACEUTICALS | BUSHRA FOR CONGRESSC00906842Primary 2026 (P2026)Filing 1970998 · amended |
| 2025-12-28FEC filing ↗ | $3,500 | AHMED, SHAHIDVERNON HILLSIL60061CHIEF SCIENTIFIC OFFICERNEXUS PHARMACEUTICALS | BUSHRA FOR CONGRESSC00906842General 2026 (G2026)Filing 1970998 · amended |
| 2025-12-30FEC filing ↗ | $3,500 | AHMED, AMANMIAMIFL33137BOARD MEMBERNEXUS PHARMACEUTICALS LLC | ACTBLUEC00401224Not reportedEARMARKED FOR BUSHRA FOR CONGRESS (C00906842)Filing 1953256 · amended |
| 2025-12-30FEC filing ↗ | $3,500 | AHMED, AMANVERNON HILLSIL60061BOARD MEMBERNEXUS PHARMACEUTICALS LLC | BUSHRA FOR CONGRESSC00906842General 2026 (G2026)Filing 1970998 · amended |
| 2025-09-30FEC filing ↗ | $3,500 | AHMED, AMANVERNON HILLSIL60061BOARD MEMBERNEXUS PHARMACEUTICALS LLC | ACTBLUEC00401224Not reportedEARMARKED FOR BUSHRA FOR CONGRESS (C00906842)Filing 1953256 · amended |
| 2025-09-30FEC filing ↗ | $3,500 | AHMED, AMANVERNON HILLSIL60061BOARD MEMBERNEXUS PHARMACEUTICALS LLC | BUSHRA FOR CONGRESSC00906842Primary 2026 (P2026)Filing 1970995 · amended |
Refunds remain negative. Memo-only rows are marked and are not additional money. Rows come from the latest available contribution publication.
Open full contribution table →Reported as NEXUS PHARMACEUTICALS LLC
Industry classification summary
Nexus Pharmaceuticals is a US-based pharmaceutical manufacturer specializing in generic and specialty injectable drugs, as confirmed by its own website and industry research.
AI-generated classification based on saved sources
View source